Humacyte, Inc. Inventory, Gross
Humacyte, Inc. (HUMA) had Inventory, Gross of $18.18 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Inventory
us-gaap:InventoryGross · last filed 2026-08-12
- 2026-06-30: Inventory, Gross $18.18M.
- 2026-03-31: Inventory, Gross $20.44M.
- 2025-12-31: Inventory, Gross $22.49M.
- 2024-12-31: Inventory, Gross $0.00.
| Period end | Inventory, Gross |
|---|---|
| 2026-06-30 | $18.18M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $20.44M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $22.49M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |